Company Page

Macrobiome Therapeutics is a biotechnology company harnessing the therapeutic potential of hookworms and parasitic helminths to develop drugs for chronic wounds, autoimmune diseases, and metabolic diseases. The company develops hookworm-derived recombinant proteins that suppress inflammation, targeting conditions like inflammatory bowel disease, Type 2 diabetes, rheumatoid arthritis, and asthma. Based in Cairns, the company brings together international medical research teams and has developed numerous proteins showing efficacy in animal models and ex vivo bioactivity with human tissues.

Company Founded in 2020

Healthtech & Biotech